Bionik Laboratories (BNKL) Stock Price, News & Analysis

Company Overview

Bionik Laboratories Corp., headquartered in Waltham, Massachusetts, designs, develops and markets robotics-based rehabilitation solutions and assistive devices for patients with neurological and mobility impairments. Its core product portfolio includes the ARKE lower limb exoskeleton for gait training and the InMotion series of upper extremity robotic therapy devices, such as InMotion ARM and InMotion WRIST. These systems leverage sensor-driven feedback and proprietary software to enable clinicians to deliver personalized motor rehabilitation programs.

Founded in 2008, Bionik established a foundation in exoskeleton and robotics technology before expanding its clinical product suite through strategic acquisitions and research collaborations. The company’s acquisition of Interactive Motion Technologies in 2018 brought the widely adopted InMotion platform into its operations, reinforcing its position in hospital and outpatient rehabilitation settings. Ongoing research partnerships with academic institutions and medical centers support the clinical validation of its devices and the development of next-generation therapy protocols.

Bionik serves a broad network of hospitals, rehabilitation clinics and research facilities across North America and select international markets. Through its field support teams and clinical education programs, the company trains therapists and medical professionals on integrating robotics into patient care pathways. By combining hardware, software and data analytics, Bionik aims to enhance therapy outcomes, accelerate recovery timelines and improve functional independence for individuals affected by stroke, spinal cord injury and other movement disorders.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: $1 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 6/26/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:BNKL
• CIK: 1508381
• Web: www.bioniklabs.com
• Phone: (617) 926-4800
• Fax: N/A
• Employees: 10
• Year Founded: 2009

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 6,770,000
• Free Float: N/A
• Market Cap: $1 thousand
• Optionable: Not Optionable
• Beta: N/A